First description of an uterine perforation potentially imputable to treatment with bevacizumab

MeSH terms

• Adenocarcinoma / drug therapy*
• Adenocarcinoma / secondary*
• Adult
• Angiogenesis Inhibitors / administration & dosage
• Angiogenesis Inhibitors / adverse effects*
• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bevacizumab
• Camptothecin / administration & dosage
• Camptothecin / analogs & derivatives
• Colorectal Neoplasms / blood supply
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / pathology*
• Disease Progression
• Fatal Outcome
• Female
• Fluorouracil / administration & dosage
• Humans
• Leucovorin / administration & dosage
• Liver Neoplasms / secondary
• Lung Neoplasms / secondary
• Organoplatinum Compounds / administration & dosage
• Tomography, X-Ray Computed
• Uterine Perforation / chemically induced*
• Uterine Perforation / diagnostic imaging